EZH2 and Hepatic fibrosis: To decipher the pathological relevance of EZH2 in hepatic fibrosis, we investigated in vivo phenotypes of pharmacological inhibition and genetic knockdown of EZH2 in two murine models of liver fibrosis (CCl4 and BDL).